Novel somatic mutations in primary hyperaldosteronism are related to the clinical, radiological and pathological phenotype

Clinical Endocrinology

Volumn 83, Issue 6, 2015, Pages 779-789

  Scholl, Ute I ^a,b   Healy, James M ^a   Thiel, Anne ^b   Fonseca, Annabelle L ^a   Brown, Taylor C ^a   Kunstman, John W ^a   Horne, Matthew J ^a   Dietrich, Dimo ^c   Riemer, Jasmin ^d   Kücükköylü, Seher ^b   Reimer, Esther N ^b   Reis, Anna Carinna ^e   Goh, Gerald ^a   Kristiansen, Glen ^c   Mahajan, Amit ^a   Korah, Reju ^a   Lifton, Richard P ^a   Prasad, Manju L ^a   Carling, Tobias ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY OF BONN   (Germany)

^d UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATP2B3 PROTEIN; CACNA1D PROTEIN; CTNNB1 PROTEIN; F154C PROTEIN; GENOMIC DNA; I157K PROTEIN; KCNJ5 PROTEIN; PROTEIN; SOLUTE CARRIER ORGANIC ANION TRANSPORTER 1A1; UNCLASSIFIED DRUG; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ATP1A1 PROTEIN, HUMAN; ATP2B3 PROTEIN, HUMAN; BETA CATENIN; CACNA1D PROTEIN, HUMAN; CALCIUM CHANNEL L TYPE; CTNNB1 PROTEIN, HUMAN; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; KCNJ5 PROTEIN, HUMAN; PLASMA MEMBRANE CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ADRENAL HYPERPLASIA; ADULT; AGED; ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DNA MICROARRAY KIT; EXOME; FEMALE; GENE INSERTION; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MUTATION RATE; PHENOTYPE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; SOMATIC MUTATION; WILD TYPE; DIAGNOSTIC IMAGING; GENETICS; HYPERALDOSTERONISM; MIDDLE AGED; MUTATION; PATHOLOGY; RETROSPECTIVE STUDY;

ADULT; BETA CATENIN; CALCIUM CHANNELS, L-TYPE; FEMALE; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; HUMANS; HYPERALDOSTERONISM; MALE; MIDDLE AGED; MUTATION; PLASMA MEMBRANE CALCIUM-TRANSPORTING ATPASES; RETROSPECTIVE STUDIES; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 84945157753     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12873     Document Type: Article

References (35)

1. Rossi, G.P., Bernini, G., Caliumi, C., et al,. (2006) A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. Journal of the American College of Cardiology, 48, 2293-2300.
2. Funder, J.W., Carey, R.M., Fardella, C., et al,. (2008) Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 93, 3266-3281.
3. Mosso, L., Carvajal, C., Gonzalez, A., et al,. (2003) Primary aldosteronism and hypertensive disease. Hypertension, 42, 161-165.
4. Milliez, P., Girerd, X., Plouin, P.F., et al,. (2005) Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. Journal of the American College of Cardiology, 45, 1243-1248.
5. Young, W.F., (2007) Primary aldosteronism: renaissance of a syndrome. Clinical Endocrinology, 66, 607-618.
6. Sawka, A.M., Young, W.F., Thompson, G.B., et al,. (2001) Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Annals of Internal Medicine, 135, 258-261.
7. Zarnegar, R., Young, W.F. Jr, Lee, J., et al,. (2008) The aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma. Annals of Surgery, 247, 511-518.
8. Walz, M.K., Gwosdz, R., Levin, S.L., et al,. (2008) Retroperitoneoscopic adrenalectomy in Conn's syndrome caused by adrenal adenomas or nodular hyperplasia. World Journal of Surgery, 32, 847-853.
9. Steichen, O., Zinzindohoue, F., Plouin, P.F., et al,. (2012) Outcomes of adrenalectomy in patients with unilateral primary aldosteronism: a review. Hormone and Metabolic Research, 44, 221-227.
10. Choi, M., Scholl, U.I., Yue, P., et al,. (2011) K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science, 331, 768-772.
11. Akerstrom, T., Crona, J., Delgado Verdugo, A., et al,. (2012) Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter. PLoS One, 7, e41926.
12. Boulkroun, S., Beuschlein, F., Rossi, G.P., et al,. (2012) Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism. Hypertension, 59, 592-598.
13. Scholl, U.I., &, Lifton, R.P., (2013) New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5. Current Opinion in Nephrology and Hypertension, 22, 141-147.
14. Zheng, F.F., Zhu, L.M., Nie, A.F., et al,. (2015) Clinical characteristics of somatic mutations in Chinese patients with aldosterone-producing adenoma. Hypertension, 65, 622-628.
15. Fernandes-Rosa, F.L., Williams, T.A., Riester, A., et al,. (2014) Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma. Hypertension, 64, 354-361.
16. Taguchi, R., Yamada, M., Nakajima, Y., et al,. (2012) Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas. Journal of Clinical Endocrinology and Metabolism, 97, 1311-1319.
17. Wang, B., Li, X., Zhang, X., et al,. (2015) Prevalence and characterization of somatic mutations in chinese aldosterone-producing adenoma patients. Medicine, 94, e708.
18. Wu, V.C., Huang, K.H., Peng, K.Y., et al,. (2015) Prevalence and clinical correlates of somatic mutation in aldosterone producing adenoma-Taiwanese population. Scientific Reports, 5, 11396.
19. Lenzini, L., Rossitto, G., Maiolino, G., et al,. (2015) A meta-analysis of somatic KCNJ5 K channel mutations in 1636 patients with an aldosterone-producing adenoma. Journal of Clinical Endocrinology and Metabolism, 100, E1089-E1095.
20. Spat, A., &, Hunyady, L., (2004) Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiological Reviews, 84, 489-539.
21. Oki, K., Plonczynski, M.W., Luis Lam, M., et al,. (2012) Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis. Endocrinology, 153, 1774-1782.
22. Scholl, U.I., Goh, G., Stolting, G., et al,. (2013) Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism. Nature Genetics, 45, 1050-1054.
23. Azizan, E.A., Poulsen, H., Tuluc, P., et al,. (2013) Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. Nature Genetics, 45, 1055-1060.
24. Beuschlein, F., Boulkroun, S., Osswald, A., et al,. (2013) Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nature Genetics, 45, 440-444.
25. Williams, T.A., Monticone, S., Schack, V.R., et al,. (2014) Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas. Hypertension, 63, 188-195.
26. Tadjine, M., Lampron, A., Ouadi, L., et al,. (2008) Frequent mutations of beta-catenin gene in sporadic secreting adrenocortical adenomas. Clinical Endocrinology, 68, 264-270.
27. Berthon, A., Sahut-Barnola, I., Lambert-Langlais, S., et al,. (2010) Constitutive beta-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development. Human Molecular Genetics, 19, 1561-1576.
28. Young, W.F. Jr, (2007) Clinical practice. The incidentally discovered adrenal mass. New England Journal of Medicine, 356, 601-610.
29. Harvey, A., Kline, G., &, Pasieka, J.L., (2006) Adrenal venous sampling in primary hyperaldosteronism: comparison of radiographic with biochemical success and the clinical decision-making with "less than ideal" testing. Surgery, 140, 847-853; discussion 853-845.
30. Vonend, O., Ockenfels, N., Gao, X., et al,. (2011) Adrenal venous sampling: evaluation of the German Conn's registry. Hypertension, 57, 990-995.
31. Vincent, J.M., Morrison, I.D., Armstrong, P., et al,. (1994) The size of normal adrenal glands on computed tomography. Clinical Radiology, 49, 453-455.
32. Zhang, J., Li, N., Hu, Y., et al,. (2015) Sequence analysis of coding regions of KCNJ5 gene in unilateral adrenal hyperplasia. Zhonghua Yi Xue Yi Chuan Xue Za Zhi (Chinese Journal of Medical Genetics), 32, 21-25.
33. Yamada, M., Nakajima, Y., Taguchi, R., et al,. (2012) KCNJ5 mutations in aldosterone- and cortisol-co-secreting adrenal adenomas [Rapid Communication]. Endocrine Journal, 59, 735-741.
34. Thiel, A., Reis, A.C., Haase, M., et al,. (2015) PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: a single-center study of 60 cases. European Journal of Endocrinology, 172, 677-685.
35. Azizan, E.A., Lam, B.Y., Newhouse, S.J., et al,. (2012) Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors. Journal of Clinical Endocrinology and Metabolism, 97, E819-E829.